Mabwell Announces First Patient Dosed In Phase Ii Trial Of Anti-Il-11 Antibody For Pathological Scarring
ReutersDec 30, 2025 2:04 PM
Dec 30 (Reuters) - Mabwell Shanghai Bioscience Co Ltd 688062.SS:
MABWELL ANNOUNCES FIRST PATIENT DOSED IN PHASE II TRIAL OF ANTI-IL-11 ANTIBODY FOR PATHOLOGICAL SCARRING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Silver Surges Then Flash Crashes. Safe-Haven Asset Or Speculative Bubble? What Is the Truth of Market Turmoil?
TradingKey - The global precious metals market experienced extreme volatility by the end of 2025. Silver prices plunged nearly 9% on December 29, marking the largest single-day drop since 2021. As silver futures prices plummeted, related precious metals ETFs and mining stocks also saw synchronous deTradingKey
17 hours ago
TradingKey 2025 Markets Recap & Outlook | Bitcoin Price Repeatedly Hits New Highs, 2026 Can BTC Write Another Legend?
Multiple tailwinds in 2025 propelled Bitcoin to new highs, but many of these positives have already been priced in. In 2026, Bitcoin faces challenges such as liquidity tightening, as well as regulatory and monetary policy uncertainties. Wall Street is divided on Bitcoin's future outlook, with targetTradingKey
Fri, Dec 26
TradingKey 2025 Markets Recap & Outlook | Global Central Banks 2026 amid Post‑Easing Recovery and Diverging Paths
TradingKey - In 2025, major global central banks will largely maintain an accommodative stance, but the policy pace will decelerate notably. As the easing cycle draws to a close, how will global monetary policy evolve?TradingKey
Thu, Dec 25
Ripple Price Prediction: Why Is XRP Price Falling? Can It Rise to $10 in the Future?
XRP has weakened this year due to profit-taking, capital outflows, and its correlation with Bitcoin. Despite support from potential spot ETFs and positive regulatory developments, significant market divergence, liquidity uncertainty, and macroeconomic uncertainty remain high. XRP's price is likely tTradingKey
Wed, Dec 24
Tradingkey
